The Hydration Pharmaceuticals Co (ASX:HPC) EV-to-FCF: -1.06 (As of Jun. 26, 2026)
What is The Hydration Pharmaceuticals Co EV-to-FCF?
The Hydration Pharmaceuticals CoASX:HPC -20.00% EV-to-FCF is -1.06 as of Jun. 26, 2026. The stock has 3 warning signs investors should review. Among 210 Retail - Defensive companies, The Hydration Pharmaceuticals Co ranks worse than 476190% on this metric.
The historical rank and industry rank for The Hydration Pharmaceuticals Co's EV-to-FCF or its related term are showing as below:
ASX:HPC'
s EV-to-FCF Range Over the Past 10 Years
Min: -2.31 Med: -0.35 Max: 0.64
Current: -1.16
During the past 5 years, the highest EV-to-FCF of The Hydration Pharmaceuticals Co was 0.64. The lowest was -2.31. And the median was -0.35.
ASX:HPC's EV-to-FCF is ranked worse than 100% of 210
companies
in the Retail - Defensive industry
Industry Median: 17.085
vs ASX:HPC: -1.16
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
The Hydration Pharmaceuticals Co (ASX:HPC) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
The Hydration Pharmaceuticals Co's PE Ratio (TTM) for today is calculated as:
The Hydration Pharmaceuticals Co's share price for today is A$0.004.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. The Hydration Pharmaceuticals Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.011.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
The Hydration Pharmaceuticals Co EV-to-FCF Related Terms
The Hydration Pharmaceuticals Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Hydration Pharmaceuticals Co EV-to-FCF vs Retail - Defensive Industry
For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where The Hydration Pharmaceuticals Co's EV-to-FCF falls into.
The Hydration Pharmaceuticals Co's current Enterprise Value is A$5.88 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. The Hydration Pharmaceuticals Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-5.53 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Hydration Pharmaceuticals Co (ASX:HPC) has a EV-to-FCF of -1.06 as of Jun. 26, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on The Hydration Pharmaceuticals Co and its competitors. According to the industry distribution chart, The Hydration Pharmaceuticals Co ranks #999999 out of 210 companies in the Retail - Defensive industry.
Is The Hydration Pharmaceuticals Co's EV-to-FCF too high?
The Hydration Pharmaceuticals Co's current EV-to-FCF is -1.06. Based on the distribution chart, The Hydration Pharmaceuticals Co ranks #999999 out of 210 companies in the Retail - Defensive industry, which is in the bottom quartile relative to peers.
How does The Hydration Pharmaceuticals Co's EV-to-FCF compare to SYY and USFD?
According to the Retail - Defensive industry distribution chart, The Hydration Pharmaceuticals Co ranks #999999 out of 210 companies for EV-to-FCF. This places The Hydration Pharmaceuticals Co in the lower half of its industry. The industry median EV-to-FCF is 17.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Retail - Defensive company?
The median EV-to-FCF among Retail - Defensive companies is 17.09, based on 210 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on The Hydration Pharmaceuticals Co and its competitors. For the Retail - Defensive industry, the median EV-to-FCF is 17.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Hydration Pharmaceuticals Co's current EV-to-FCF is -1.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current EV-to-FCF of -1.06. The current EV-to-FCF is -1.06. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current EV-to-FCF is -1.06 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Hydration Pharmaceuticals Co Business Description
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:HPC has been successfully added to your 